{"created":"2024-12-03T03:09:06.797954+00:00","id":2002107,"links":{},"metadata":{"_buckets":{"deposit":"ebbeae3d-b1f5-4385-a54c-28b09f650091"},"_deposit":{"created_by":8,"id":"2002107","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"2002107"},"status":"published"},"_oai":{"id":"oai:fmu.repo.nii.ac.jp:02002107","sets":["1732778801467:1732778962699:1733193809282"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Caution: Patient-specific preoperative preparations combined with procedure-specific 5-aminolevulinic acid may lead to critical events","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yoshizawa, Shuto","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yoshida, Junya","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yoshihara, Akioh","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nemoto, Chiaki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Inoue, Satoki","creatorNameLang":"en"}]}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"© 2024 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.","subitem_rights_language":"en","subitem_rights_resource":"https://creativecommons.org/licenses/by-nc-sa/4.0/"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"5-aminolevulinic acid","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"cerebral infarction","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"transurethral resection of bladder tumor","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Humans","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Male","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Aminolevulinic Acid","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Aged, 80 and over","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Urinary Bladder Neoplasms","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Hypotension","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Cerebral Infarction","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Preoperative Care","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"},{"subitem_subject":"Photosensitizing Agents","subitem_subject_language":"en","subitem_subject_scheme":"MeSH"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"5-Aminolevulinic acid (5-ALA) is orally administered 2-4 hours before surgery to identify tumor location. Hypotension is sometimes observed after 5-ALA administration. Case reoprtWe present a case of a patient with 5-ALA-induced hypotension that resulted in the development of cerebral infarction. An 83-year-old man with a bladder tumor was scheduled for photodynamic diagnosis-assisted transurethral resection of bladder tumor (PDD-TURBT) and right radical nephroureterectomy. 5-ALA was orally administered and his ordinary antihypertensive and antianginal agents were also administered an hour after 5-ALA administration. Following this, his blood pressure dropped, and he developed muscle weakness and paralysis in his left upper extremity. Magnetic resonance imaging showed evidence of cerebral infarction. ConclusionsWe cannot conclude definitively that our patient's cerebral infarction was solely caused by 5-ALA-induced hypotension because hypotension under these circumstances is not rare. We consider that additional factors, such as patient-specific doses of antihypertensive and antianginal agents may have played a role in the development of his cerebral infarction.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"The Fukushima Society of Medical Science","subitem_publisher_language":"en"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"0016-2590","subitem_source_identifier_type":"PISSN"},{"subitem_source_identifier":"2185-4610","subitem_source_identifier_type":"EISSN"},{"subitem_source_identifier":"AA0065246X","subitem_source_identifier_type":"NCID"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2024","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"173","bibliographicPageStart":"169","bibliographicVolumeNumber":"70","bibliographic_titles":[{"bibliographic_title":"Fukushima Journal of Medical Science","bibliographic_titleLang":"en"}]}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.5387/fms.24-00001","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"38925956","subitem_relation_type_select":"PMID"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2024-07-26"}],"displaytype":"detail","filename":"FksmJMedSci_70_p169.pdf","filesize":[{"value":"465.1 KB"}],"format":"application/pdf","mimetype":"application/pdf","url":{"url":"https://fmu.repo.nii.ac.jp/record/2002107/files/FksmJMedSci_70_p169.pdf"},"version_id":"e66c392d-9fc5-4f0b-8ccb-47e15d2edf2e"}]},"item_title":"Caution: Patient-specific preoperative preparations combined with procedure-specific 5-aminolevulinic acid may lead to critical events","item_type_id":"40002","owner":"8","path":["1733193809282"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2024-07-26"},"publish_date":"2024-07-26","publish_status":"0","recid":"2002107","relation_version_is_last":true,"title":["Caution: Patient-specific preoperative preparations combined with procedure-specific 5-aminolevulinic acid may lead to critical events"],"weko_creator_id":"8","weko_shared_id":-1},"updated":"2024-12-03T03:15:30.633314+00:00"}